http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
ResMed (RMD) Says European Patents Infringed by Fisher & Paykel in Germany
-
ResMed's European Patents Infringed by Fisher & Paykel in Germany
-
ResMed to Announce First Quarter Fiscal Year 2018 Results
-
Sommetrics Expands Board of Directors and Management Team to Prepare for Canadian Launch of New Sleep Apnea Therapy
-
ResMed to Announce Fourth Quarter Fiscal Year 2017 Results
-
Big Data Yields Big Insights for Treatment of Central Sleep Apnea
-
Clinical Trial Published in JAMA Offers New Hope for COPD Patients
-
Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel
-
Introducing the Softest CPAP Mask from ResMed
-
ResMed Unveils AirMini - the World's Smallest CPAP
-
New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Sleep Apnea
-
ResMed to Announce Third Quarter Fiscal Year 2017 Results
-
Research on Treating Sleep Apnea with Adaptive Servo-ventilation Published in the Journal of the American College of Cardiology (JACC)
-
ResMed Named Global Leader in Remote Patient Monitoring
-
ResMed and BMC/3B Medical Settle Global Litigation
-
ResMed (RMD) myAir Patients With Sleep Apnea Have Greater Adherance To CPAP - Price Waterhouse Coopers Research
-
ResMed's myAir™ Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea
-
FDA Clears World's Smallest CPAP, ResMed AirMini™
-
Dr. Oz, ResMed Launch SleepScore Labs - Promising the World a Better Night's Sleep
-
ResMed Reaches Historic One Billionth Night of Sleep Monitored
-
ResMed (RMD) Names Carlos Nunez as CMO
-
ResMed Appoints Carlos Nunez, MD, as Chief Medical Officer
-
ResMed to Announce Second Quarter Fiscal Year 2017 Results
-
ResMed Launches AirView Action Groups, the Ultimate Time-saver For Home Medical Equipment Providers
-
ResMed Introduces AirFit™ N20 and AirFit F20 CPAP Masks: A New Standard for Fit and Comfort
-
Results from World's Largest Study on Sleep Apnea and Digital Connected Care
-
How Technology is Tackling the World's Greatest Healthcare Challenges in the Era of Personalized Medicine, at the Digital Health Summit at CES 2017
-
National Sleep Survey Launch on "The Dr. Oz Show" to Determine America's Sleep Score
-
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
-
ResMed to Announce First Quarter Fiscal Year 2017 Results
-
New Study Shows Using Non-Invasive Ventilation Therapy to Treat Patients with Chronic Obstructive Pulmonary Disorder (COPD) at Home Significantly Reduces Risk of Re-Hospitalization and Death
-
New Study Shows Using Non-Invasive Ventilation Therapy to Treat Patients with Chronic Obstructive Pulmonary Disorder (COPD) at Home Significantly Reduces Risk of Re-Hospitalization and Death
-
ResMed (RMD) Announces Positive Data from HOT-HMV Study in NIV
-
ResMed Expands COPD Offering as New Data Reveals Benefits of Home Non-Invasive Ventilation
-
ResMed Takes Fisher & Paykel to Court over Patents
-
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2016
-
ResMed to Announce Fourth Quarter Fiscal Year 2016 Results
-
ResMed Awarded Group Purchasing Contract with Premier
-
ResMed Statement on Brightree Executive Appointments
-
Kaiser Permanente Study: ResMed Digital Platform Drives CPAP Adherence
-
Adaptive Servo-ventilation (ASV) Therapy Suggests Positive Cardiovascular Outcomes for People with Sleep-Disordered Breathing and Heart Failure With Preserved Ejection Fraction In Phase II Study
-
ResMed Life Support Ventilators to Join World's Largest Remote Patient Monitoring Network
-
International Trade Commission to Investigate Chinese Manufacturer BMC Medical's Infringement of ResMed Patents
-
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2016
-
It's a New Day for HME Business Efficiency
-
ResMed to Announce Third Quarter Fiscal Year 2016 Results
-
Battery Ventures-Backed Software Company Brightree LLC to Be Acquired for $800 Million
-
ResMed to Acquire Brightree® for $800 Million
-
ResMed (RMD) Announces Completion of Inova Labs Acquisition
-
ResMed Completes Acquisition of Inova Labs

